Cargando…

Raynaud’s Secondary to Granulomatosis With Polyangiitis

Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA)...

Descripción completa

Detalles Bibliográficos
Autores principales: Vulasala, Sai Swarupa, Ahmed, Shohana, Onteddu, Nirmal K, Mannem, Maneesh, Mukkera, Srikanth
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Cureus 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481133/
https://www.ncbi.nlm.nih.gov/pubmed/34646608
http://dx.doi.org/10.7759/cureus.17551
_version_ 1784576617547300864
author Vulasala, Sai Swarupa
Ahmed, Shohana
Onteddu, Nirmal K
Mannem, Maneesh
Mukkera, Srikanth
author_facet Vulasala, Sai Swarupa
Ahmed, Shohana
Onteddu, Nirmal K
Mannem, Maneesh
Mukkera, Srikanth
author_sort Vulasala, Sai Swarupa
collection PubMed
description Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA) that presented with ischemia and gangrene. Studies show that approximately <1% of GPA cases have similar presentations. Early diagnosis and management are essential to halt the progression of ischemia. Calcium channel blockers are the first-line medications used in RP. Phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, and prostacyclin analogs are proven to be effective in cases of severe RP. Sympathectomy and amputation are considered as the extreme options in patients with refractory symptoms.
format Online
Article
Text
id pubmed-8481133
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Cureus
record_format MEDLINE/PubMed
spelling pubmed-84811332021-10-12 Raynaud’s Secondary to Granulomatosis With Polyangiitis Vulasala, Sai Swarupa Ahmed, Shohana Onteddu, Nirmal K Mannem, Maneesh Mukkera, Srikanth Cureus Dermatology Raynaud’s phenomenon (RP) is an episodic digital vasospastic condition that is prevalent among 5% of the population. The symptoms range from reversible pallor to ischemia and gangrene. RP can be primary or secondary. We discuss a case of severe RP secondary to granulomatosis with polyangiitis (GPA) that presented with ischemia and gangrene. Studies show that approximately <1% of GPA cases have similar presentations. Early diagnosis and management are essential to halt the progression of ischemia. Calcium channel blockers are the first-line medications used in RP. Phosphodiesterase type 5 inhibitors, endothelin receptor antagonists, and prostacyclin analogs are proven to be effective in cases of severe RP. Sympathectomy and amputation are considered as the extreme options in patients with refractory symptoms. Cureus 2021-08-30 /pmc/articles/PMC8481133/ /pubmed/34646608 http://dx.doi.org/10.7759/cureus.17551 Text en Copyright © 2021, Vulasala et al. https://creativecommons.org/licenses/by/3.0/This is an open access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
spellingShingle Dermatology
Vulasala, Sai Swarupa
Ahmed, Shohana
Onteddu, Nirmal K
Mannem, Maneesh
Mukkera, Srikanth
Raynaud’s Secondary to Granulomatosis With Polyangiitis
title Raynaud’s Secondary to Granulomatosis With Polyangiitis
title_full Raynaud’s Secondary to Granulomatosis With Polyangiitis
title_fullStr Raynaud’s Secondary to Granulomatosis With Polyangiitis
title_full_unstemmed Raynaud’s Secondary to Granulomatosis With Polyangiitis
title_short Raynaud’s Secondary to Granulomatosis With Polyangiitis
title_sort raynaud’s secondary to granulomatosis with polyangiitis
topic Dermatology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8481133/
https://www.ncbi.nlm.nih.gov/pubmed/34646608
http://dx.doi.org/10.7759/cureus.17551
work_keys_str_mv AT vulasalasaiswarupa raynaudssecondarytogranulomatosiswithpolyangiitis
AT ahmedshohana raynaudssecondarytogranulomatosiswithpolyangiitis
AT onteddunirmalk raynaudssecondarytogranulomatosiswithpolyangiitis
AT mannemmaneesh raynaudssecondarytogranulomatosiswithpolyangiitis
AT mukkerasrikanth raynaudssecondarytogranulomatosiswithpolyangiitis